Super-acute onset of tumor lysis syndrome accompanied by hypercytokinemia during treatment of Hodgkin's lymphoma with ABVD chemotherapy

Abstract Background: Tumor lysis syndrome (TLS) is a group of life-threatening metabolic complications that can occur after initiation of cancer chemotherapy. Onset of TLS in the middle of chemotherapy, however, has not been reported previously in patients with hematologic malignancies. Objective: W...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical therapeutics 2010-03, Vol.32 (3), p.527-531
Hauptverfasser:	Suzuki, Takaaki, MS, Takeuchi, Masahiro, MD, PhD, Saeki, Hiromi, MS, Yamazaki, Shingo, MS, Koga, Hitomi, MS, Abe, Daijiro, MD, PhD, Nishimura, Miki, MD, PhD, Nakaseko, Chiaki, MD, PhD, Nakasa, Hiromitsu, PhD, Nakamura, Hiroyoshi, PhD, Ariyoshi, Noritaka, PhD, Kitada, Mitsukazu, PhD
Format:	Artikel
Sprache:	eng
Schlagworte:	acute Acute Disease Adult Antineoplastic Combined Chemotherapy Protocols - administration & dosage Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biological and medical sciences Bleomycin - administration & dosage Bleomycin - adverse effects Dacarbazine - administration & dosage Dacarbazine - adverse effects Doxorubicin - administration & dosage Doxorubicin - adverse effects Fever - chemically induced Hematologic and hematopoietic diseases Hodgkin Disease - drug therapy Humans hypercytokinemia Interleukin-6 - blood Internal Medicine Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis lymphoma Male Medical Education Medical sciences Pharmacology. Drug treatments Seizures, Febrile - chemically induced tumor lysis syndrome Tumor Lysis Syndrome - etiology Tumor Lysis Syndrome - physiopathology Unconsciousness - chemically induced Vinblastine - administration & dosage Vinblastine - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!